Biorez, Inc.
Industry
- Medical Devices
- Biomaterials
- Implantable Devices
- Surgical Equipment & Devices
- Biotechnology
Other Names/Subsidiaries
- Soft Tissue Regeneration
Latest on Biorez, Inc.
Biopharma Acquisitions Biopharma merger and acquisition value for the third quarter of 2022 reached $15.4bn from 41 transactions, 21 of which had disclosed values. Four M&A transactions hit or exceede
Silver wire and carbon fiber; polyethylene, Dacron , and Gor-Tex : these are just some among the synthetic materials device makers have fashioned into ropes, cuffs, and straps to replace torn and ru
Vertebral Compression Fracture Approval The minimally invasive vertebral compression fracture (VCF) device market, which has faced controversy and reduced procedure volumes in recent years due to conc
by Sharon O'Reilly With the growing trend toward less invasive surgery and preventive approaches to stave off the joint degenerative process, it should come as no surprise that sports medicine is the